Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR (95 % CI) | χ 2 | P | HR (95 % CI) | χ 2 | P | |
Age (years) | 1.176 (0.530-2.611) | 0.159 | 0.690 | - | - | - |
<65 | ||||||
≥65 | ||||||
Histotype | 1.390 (0.969-1.993) | 3.198 | 0.074 | 2.015 (1.296-3.134) | 9.680 | 0.002* |
Serous | ||||||
Others | ||||||
Grade | - | - | - | |||
G1-2 | 1.318 (0.862-2.016) | 1.627 | 0.202 | |||
G3 | ||||||
Ascites (mL) | 1.021 (0.576-1.811) | 0.005 | 0.943 | - | - | - |
<1000 | ||||||
>1000 | ||||||
Residual tumor (cm) | 3.814 (1.946-7.476) | 15.204 | <0.0001* | 2.736 (1.271-5.890) | 6.617 | 0.010* |
<1 | ||||||
≥1 | ||||||
Response to chemotherapy | 5.627 (3.078-10.289) | 31.483 | <0.0001* | 5.318 (2.677-10.564) | 22.770 | <0.0001* |
PR | ||||||
PD | ||||||
Class III β-tubulin | 1.347 (0.776-2.339) | 1.119 | 0.290 | - | - | - |
Positive | ||||||
Negative | ||||||
Sox2 | 1.537 (0.863-2.736) | 2.128 | 0.145 | - | - | - |
Positive | ||||||
Negative | ||||||
Nuclear Survivin | 1.399 (0.813-2.407) | 1.472 | 0.225 | - | - | - |
Positive | ||||||
Negative | ||||||
Cytoplasmic Survivin | 1.206 (0.643-2.261) | 0.341 | 0.559 | - | - | - |
Positive | ||||||
Negative |